With medical technologies as a focus of the New South Wales Premier’s Trade Mission to Israel last week, a partnership in cellular genomics research has been established between Sydney’s Garvan Institute of Medical Research and Israel’s Weizmann Institute.
The Garvan-Weizmann Centre for Cellular Genomics will be housed in The Kinghorn Cancer Centre in Darlinghurst. The research facility will be Australia’s only multidisciplinary facility for cellular genomics and the NSW Government will contribute $5 million in funding.
“This partnership will create a bridge between these two innovative and world leading research bodies,” Mr Baird said. “By building the first facility of this kind in our part of the world, we can continue NSW leadership in scientific and medical research.”
Cellular genomics is an emerging field of technology that examines differences in genetic sequences and gene expressions in human cells. It is crucial to diagnosing and treating disease, including cancer and autoimmune diseases.
The facility will house a team of over 50 specialists who will detail how human genomes operate at the level of the individual cell in order to understand complex diseases such as cancer. The partnership will bring the Weizmann Institute’s experience in science education to NSW, including targeted programs that will help science teachers teach genomics to middle and high school students.
Original article published on Jwire.com